Sparrow to join U-M Health under proposed agreement

Author | Mary Masson

LANSING, MI – Sparrow Health System will join University of Michigan Health under a proposed agreement that will expand services to mid-Michigan residents, provide access to the highest level of care, improve facilities and technology, and begin a new chapter in Sparrow’s storied history.

The U-M Board of Regents approved moving ahead with the agreement at its Dec. 8 meeting, as did the Sparrow Health System Board of Directors on Nov. 28. The agreement is expected to be completed in the first half of 2023, pending final regulatory approvals and completion of the closing process.

Joining U-M Health will have a far-reaching impact on Sparrow and mid-Michigan, expanding access to clinical care throughout the region and, ultimately, statewide.

“The partnership with University of Michigan Health provides Sparrow the opportunity to take a greater leadership role in improving the health of the communities we serve,” said Sparrow Health System President and CEO James F. Dover. 

Added Sparrow Health System Board Chair John Pirich: “This enables Sparrow to achieve our long-term strategy of helping to create a statewide system of care and allows us to accelerate growth and continue our 126-year commitment to providing world-class care close to home.”

U-M President Santa Ono pointed out that an affiliation agreement signed by the two organizations in 2019 for pediatric services paved the way for ongoing collaboration between the two systems. 

“The mission, vision and values of the two organizations are aligned with a common goal to deliver on the promise of nationally renowned clinical excellence in an accessible setting,” he said.

According to Paul Brown, chair of the U-M Board of Regents, “This agreement strengthens U-M Health’s ability to provide quality healthcare in communities beyond southeast Michigan, expanding our mission as a statewide referral site for the most critically ill.”

“For University of Michigan Health, this is an important step toward our long-term vision of a statewide system of highly coordinated care; a vision that Sparrow also embraces and is excited to build toward,” said Marschall S. Runge, M.D., Ph.D., CEO of Michigan Medicine, dean of the U-M Medical School and executive vice president for medical affairs at the University of Michigan. 

“Upon closing, U-M Health will create a clinical care network that builds upon the strengths of the world-class U-M academic medical center and a very successful community-based health system. Together the two organizations will focus on bringing increased health care innovation to mid-Michigan and beyond.”

LaKeeya Tucker, D.O., medical chief of staff for E.W. Sparrow Hospital, said as a clinician she is excited about working with her U-M Health colleagues to improve access to world-class care throughout the region.

“We are doing something special here by combining the community care and know-how that Sparrow has long been known for with the clinical expertise and commitment of U-M Health,” Tucker said.

University of Michigan Health has committed $800 million in investment to Sparrow Health System, which will be funded through facility projects, operations, and strategic investments over eight years.

“We will invest in numerous improvement and growth initiatives based on community need, such as renovations to our Neonatal Intensive Care Unit at E.W. Sparrow Hospital in Lansing and geographic growth across the communities we serve.  This will also strengthen our key service lines including cardiology, oncology, orthopedics, and neuroscience,” noted Joseph Ruth, Sparrow Health System’s executive vice president and chief operating officer. “This infusion of investment into Sparrow services will provide job growth and career development opportunities that would not otherwise be available to our caregivers.”

According to U-M Health President David Miller, M.D., M.P.H.: “This agreement builds upon the successful partnership formed through U-M Health at Sparrow Children’s Center. This established partnership has clarified the strong cultural alignment between U-M Health and Sparrow, while providing incredibly important pediatric care to families throughout Mid-Michigan. Our expanded partnership with Sparrow will further strengthen U-M Health’s ability to provide quality health care in communities beyond southeast Michigan.” 

The partnership will also build on U-M Health’s minority investment in Sparrow’s health plan, Physicians Health Plan (PHP). PHP provides high-quality healthcare coverage to more than 70,000 members and 300 employers across Michigan and includes a Medicare Advantage plan.

Sparrow has more than 115 sites of care, including E.W. Sparrow Hospital in Lansing, community hospitals in Carson City, Charlotte, Ionia and St. Johns, Sparrow Specialty Hospital, and nearly 500 Sparrow primary care providers and specialists serving patients across the region.  

With the addition of Sparrow, U-M Health will become a $7-billion organization with more than 200 care sites across the state.

More information is available at www.uofmhealth.org/sparrow.

About Sparrow:

Sparrow is Mid-Michigan’s premier healthcare organization and includes hospitals in Lansing, Carson City, Charlotte, Ionia, and St. Johns, as well as Sparrow Specialty Hospital, Physicians Health Plan, Sparrow Care Network, Sparrow Medical Group, Michigan Athletic Club, and AL!VE.  Through our partnerships and the dedication of our 10,000 Caregivers, Sparrow pursues a vision to be nationally recognized as a leader in quality and Patient experience. 

For more information, visit www.sparrow.org

About Michigan Medicine:

At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our five hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and University of Michigan Health, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center, Kellogg Eye Center, University of Michigan Health West and the Rogel Cancer Center. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

More information is available at www.uofmhealth.org

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
If they don't give up, how can I give up?
Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
From Patients to Progress: Advancing Autoimmune Research
Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
stethoscope
Health Lab
More oversight of donated tissue products urgently needed, say experts and Michigan policymakers
A JAMA viewpoint outlines the tragic story of Shandra Eisenga, a patient who received spine surgery for back pain only to inexplicably contract tuberculosis.